TiGenix: European Patent Office issues key patent to TiGenix for expanded adipose-derived stem cell compositions
LEUVEN, Belgium, Jan. 22, 2015 (GLOBE NEWSWIRE) — TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platform of allogeneic expanded adipose-derived … This Post Originally Appeared via Bing News